Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HUM Humana	$235.58 +0.1%	$249.53	$212.45 ▼ $406.46	$28.39B	0.43	1.79 million shs	2.31 million shs
SZL GeneNews		C$0.00	C$0.00 ▼ C$0.00	N/A	N/A	N/A	N/A

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HUM Humana	+0.30%	+1.09%	-0.77%	-12.70%	-34.37%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HUM Humana	4.5122 of 5 stars	3.2	3.0	2.5	3.9	2.6	1.7	1.3
SZL GeneNews	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HUM Humana	2.30	Hold	$284.24	20.65% Upside
SZL GeneNews	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SZL, IPF, HUM, and HAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/12/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$273.00 ➝ $268.00
6/2/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$322.00 ➝ $273.00
5/12/2025	HUM Humana	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$325.00 ➝ $305.00
5/1/2025	HUM Humana	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$290.00 ➝ $290.00
5/1/2025	HUM Humana	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$300.00 ➝ $310.00
5/1/2025	HUM Humana	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$315.00
4/15/2025	HUM Humana	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$270.00 ➝ $300.00
4/11/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$270.00 ➝ $322.00
4/11/2025	HUM Humana	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$290.00 ➝ $325.00
4/9/2025	HUM Humana	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$326.00

(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HUM Humana	$120.26B	0.24	$20.72 per share	11.37	$136.57 per share	1.72
SZL GeneNews	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HUM Humana	$1.21B	$14.14	23.68	17.94	2.05	1.02%	11.70%	3.99%	7/30/2025 (Estimated)
SZL GeneNews	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest SZL, IPF, HUM, and HAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/30/2025	Q1 2025	HUM Humana	$10.07	$11.58	+$1.51	$10.30	$32.00 billion	$32.11 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HUM Humana	$3.54	1.50%	N/A	25.04%	N/A
SZL GeneNews	N/A	N/A	N/A	N/A	N/A

Latest SZL, IPF, HUM, and HAT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/17/2025	HUM Humana	quarterly	$0.8850	1.24%	6/27/2025	6/27/2025	7/25/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HUM Humana	0.68	1.76	1.76
SZL GeneNews	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HUM Humana	92.38%
SZL GeneNews	N/A

Insider Ownership

Company	Insider Ownership
HUM Humana	0.37%
SZL GeneNews	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HUM Humana	67,100	120.69 million	120.03 million	Optionable
SZL GeneNews	N/A	N/A	N/A	Not Optionable

SZL, IPF, HUM, and HAT Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SZL, IPF, HUM, and HAT Company Descriptions

Humana NYSE:HUM

$235.58 +0.32 (+0.14%)

Closing price 06/16/2025 03:59 PM Eastern

Extended Trading

$235.84 +0.26 (+0.11%)

As of 04:30 AM Eastern

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

GeneNews TSE:SZL

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time